Unigene Laboratories, Inc. (OTC BB: UGNE)

Unigene Laboratories, Inc. (OTC BB: UGNE), a biopharmaceutical company, engages in the research, production and delivery of small proteins that have shown or may potentially demonstrate medical benefits. In addition to the company’s patented manufacturing technology designed to produce many peptides cost-effectively, Unigene has patented oral and nasal delivery technologies that have demonstrated the ability to deliver medically useful amounts of various peptides into the bloodstream. For further information, visit the Company’s web site at www.unigene.com.